Workflow
Achieve Life Sciences(ACHV) - 2024 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 22722 29th Drive SE, Suite 100, Bothell, WA 98021 1040 West Georgia Street, Suite 1030, Vancouver, British Columbia, Canada V6E 4H1 (Address of Principal Executive Offices) (604) 210-2217 (Registra ...